News

2021.02.19

Dr. Hatou introduced our business plan in RINK FESTIVAL 2021.

Tokyo (Feb 19, 2021)-, Dr. Hatou, founder & CEO of Cellusion Inc., introduced our business plan in RINK FESTIVAL 2021 held online on Feb. 19th.

Details on RINK FESTIVAL 2021, please see below. https://rinkrink.jp/2021/01/07/rink-festival-2021%E9%96%8B%E5%82%AC%E3%81%AE%E3%81%8A%E7%9F%A5%E3%82%89%E<>3%81%9B/

RINK FESTIVAL 2021 was recorded and has been distributed at the following link.
URL:
https://www.youtube.com/watch?v=pA4EPG-XmrY&list=PL8eIHBk7iojlZrNVxVrBcJ5h6MT63jUEG&index=6
Availability period:
March 4th, 2021 – March 31st,2021

For further information: please ask us through contact form in our website.

<About Cellusion Inc.>
Cellusion Inc. is a regenerative medicine startup from Keio University. The mission of Cellusion is to deliver novel therapies for all bullous keratopathy patients by our iPS cells origin corneal endothelial cells mass culture system.

Company : Cellusion Inc.
CEO : Shin Hatou, M.D., Ph.D.
Headquarter :1-13-7 Nihombashi-Muromachi, Chuo, Tokyo 103-0022, JAPAN
Founded : January 2015
URL : https://cellusion.jp/en/

COPYRIGHT CELLUSION ALL RIGHTS RESERVED.